Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 2

2(25.0%)

Phase 4

1(12.5%)

Early Phase 1

1(12.5%)

8Total

N/A(4)

Phase 2(2)

Phase 4(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT00830453Phase 2Completed

Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury

Role: collaborator

NCT00465855Phase 4Completed

One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning

Role: collaborator

NCT01126515Completed

Functional and Anatomical Magnetic Resonance Imaging (MRI) of Chronic Brain Injury and Hyperbaric Oxygen (HBO2) Study Subjects

Role: collaborator

NCT00488033Not ApplicableCompleted

Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64

Role: collaborator

NCT01688440Early Phase 1Completed

ETCare: Safety and Preliminary Efficacy Trial

Role: collaborator

NCT00551746Not ApplicableCompleted

The Purple Grape Juice Study

Role: collaborator

NCT00403507Phase 2Completed

Exercise Treatment of Mild-Stage Probable Alzheimer's Disease

Role: collaborator

NCT00333697Not ApplicableCompleted

Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients

Role: collaborator

NCT01059708Terminated

Outcome Following Carbon Monoxide Poisoning in Children

Role: collaborator

NCT00334464Not ApplicableCompleted

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

Role: collaborator

All 10 trials loaded